Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
boston blog main
boston top stories
san francisco blog main
deals
fda
investing
medical device
new york blog main
new york top stories
san francisco top stories
biotech ipos
boston
cancer drugs
dihydroergotamine
europe blog main
national top stories
nirogacestat
renaissance capital
satsuma pharmaceuticals
springworks therapeutics
startups
10x genomics
480 biomedical
acute migrane
acute myeloid leukemia
ally bridge group
alx oncology
arsenal medical
autoimmune diseases
bain capital
bausch health
berkeley lights
big data analytics
black diamond therapeutics
blackrock
bladder cancer
What
biotech
6
×
ipo
6
×
companies
new
drug
raised
company
days
hasn’t
ipos
lead
leading
life
markets
medicines
million
public
raises
research
satsuma
science
slowed
springworks
street
therapeutics
wall
way
week
welcomed
activity
analysis
arrival
bio
black
boost
bring
cancer
clinic
debut
develop
Language
unset
Current search:
biotech
×
ipo
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs